20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Key Applications of Rivaroxaban: From Orthopedics to Cardiology

NINGBO INNO PHARMCHEM CO.,LTD. is pleased to outline the comprehensive range of applications for rivaroxaban, an advanced oral direct factor Xa inhibitor. Its utility spans across multiple critical medical areas, from orthopedic recovery to managing chronic cardiovascular conditions. The 'key applications of rivaroxaban' demonstrate its versatility in modern medicine.

Prevention of Venous Thromboembolism (VTE) after Orthopedic Surgery: Following major orthopedic procedures like hip or knee replacement, patients are at a significantly increased risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE). Rivaroxaban is a leading choice for thromboprophylaxis, significantly reducing the incidence of these potentially life-threatening events. This is a primary focus for the 'long-tail keyword: prevention of venous thromboembolism'.

Stroke and Systemic Embolism Prevention in Non-Valvular Atrial Fibrillation (NVAF): For individuals with NVAF, the irregular heartbeat can lead to the formation of blood clots in the heart that may travel to the brain, causing a stroke. Rivaroxaban offers effective stroke prevention in this patient group, providing a convenient oral alternative to warfarin.

Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Rivaroxaban is indicated for the acute treatment of DVT and PE, and for the extended treatment to prevent their recurrence. This dual role in treatment and secondary prevention makes it a cornerstone therapy for venous thromboembolic disease.

Prevention of Recurrent DVT and PE: Patients who have experienced a DVT or PE are at higher risk of recurrence. Rivaroxaban's efficacy in extended treatment regimens helps mitigate this risk, offering long-term protection.

Prevention of Atherothrombotic Events in Coronary Artery Disease (CAD): In certain patient populations with established CAD, rivaroxaban, when used in combination with antiplatelet therapy, has shown benefit in reducing the risk of major adverse cardiovascular events.

The broad spectrum of approved uses for rivaroxaban underscores its importance as a versatile and effective anticoagulant, addressing critical needs in both acute and chronic disease management.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Rivaroxaban's Pharmacological Profile: Absorption, Distribution, Metabolism, and Excretion

Next: The Future of Anticoagulation: Innovations and Trends Beyond Factor Xa Inhibitors

All Rights Reserved